Form 8-K - Current report:
SEC Accession No. 0001628280-21-016406
Filing Date
2021-08-10
Accepted
2021-08-10 16:11:31
Documents
14
Period of Report
2021-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bvs-20210810.htm   iXBRL 8-K 41839
2 EX-99.1 bioventusex-991q22021.htm EX-99.1 476467
6 image_0.jpg GRAPHIC 50612
  Complete submission text file 0001628280-21-016406.txt   768258

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bvs-20210810.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bvs-20210810_lab.xml EX-101.LAB 25998
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bvs-20210810_pre.xml EX-101.PRE 13732
7 EXTRACTED XBRL INSTANCE DOCUMENT bvs-20210810_htm.xml XML 12312
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 211160003
SIC: 3841 Surgical & Medical Instruments & Apparatus